Renal cell carcinoma (RCC) is classically regarded as extremely resistant to classical fractionated radiation therapy (RT). Nowadays, there is convincing data supporting RCC radiosensitivity to high fraction doses, which may represent an ideal issue for new treatment strategies in primary and oligometastatic RCC disease. This review discusses the role of RT in RCC and its potential therapeutic scenario focusing on the most interesting clinical trials
Renal Cell Carcinoma (RCC) has historically been considered a radioresistant cancer, and radiotherap...
International audienceThe prognosis of metastatic renal cell carcinoma is poor, with a median 5-year...
Purpose: To review the role of radiotherapy (RT) in the treatment of renal cell cancer (RCC) in the ...
The growing incidence of renal cell carcinoma (RCC) raises many questions about the management of th...
The growing incidence of renal cell carcinoma (RCC) raises many questions about the management of th...
Conventional radiotherapy previously had a limited role in the definitive treatment of renal cell ca...
For both primary and metastatic renal cell carcinoma (RCC), treatment with stereotactic body radioth...
For both primary and metastatic renal cell carcinoma (RCC), treatment with stereotactic body radioth...
Renal cell carcinoma (RCC) has traditionally been regarded as radioresistant tumor based on preclini...
Renal-cell carcinoma is considered to be a radioresistant tumour, but this notion might be wrong. If...
Renal-cell carcinoma is considered to be a radioresistant tumour, but this notion might be wrong. If...
Renal-cell carcinoma is considered to be a radioresistant tumour, but this notion might be wrong. If...
Renal-cell carcinoma is considered to be a radioresistant tumour, but this notion might be wrong. If...
Renal cell carcinoma (RCC) is an immunogenic tumor, but uses several immune-suppressive mechanisms t...
Renal Cell Carcinoma (RCC) has historically been considered a radioresistant cancer, and radiotherap...
Renal Cell Carcinoma (RCC) has historically been considered a radioresistant cancer, and radiotherap...
International audienceThe prognosis of metastatic renal cell carcinoma is poor, with a median 5-year...
Purpose: To review the role of radiotherapy (RT) in the treatment of renal cell cancer (RCC) in the ...
The growing incidence of renal cell carcinoma (RCC) raises many questions about the management of th...
The growing incidence of renal cell carcinoma (RCC) raises many questions about the management of th...
Conventional radiotherapy previously had a limited role in the definitive treatment of renal cell ca...
For both primary and metastatic renal cell carcinoma (RCC), treatment with stereotactic body radioth...
For both primary and metastatic renal cell carcinoma (RCC), treatment with stereotactic body radioth...
Renal cell carcinoma (RCC) has traditionally been regarded as radioresistant tumor based on preclini...
Renal-cell carcinoma is considered to be a radioresistant tumour, but this notion might be wrong. If...
Renal-cell carcinoma is considered to be a radioresistant tumour, but this notion might be wrong. If...
Renal-cell carcinoma is considered to be a radioresistant tumour, but this notion might be wrong. If...
Renal-cell carcinoma is considered to be a radioresistant tumour, but this notion might be wrong. If...
Renal cell carcinoma (RCC) is an immunogenic tumor, but uses several immune-suppressive mechanisms t...
Renal Cell Carcinoma (RCC) has historically been considered a radioresistant cancer, and radiotherap...
Renal Cell Carcinoma (RCC) has historically been considered a radioresistant cancer, and radiotherap...
International audienceThe prognosis of metastatic renal cell carcinoma is poor, with a median 5-year...
Purpose: To review the role of radiotherapy (RT) in the treatment of renal cell cancer (RCC) in the ...
DOI
Add to ORKG